2312232
Last Update Posted: 2015-02-18
Recruiting has ended
Males accepted | 18 Years-65 Years |
20 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Pharmacokinetic Study in Healthy Males
The purpose of this study is to investigate the pharmacokinetics of levodopa, carbidopa, 3-OMD and ODM-104 after repeated doses of 3 levodopa formulations given in combination with carbidopa and ODM-104.
Eligibility
Relevant conditions:
Parkinson's Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov